Elekta AB ADR | Balance Sheet

Fiscal year is May-April. All values SEK Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
2,350
3,348
2,320
3,475
4,711
4,118
Total Accounts Receivable
6,159
6,486
3,837
5,911
5,551
6,073
Inventories
1,145
1,347
1,198
1,039
1,192
2,634
Other Current Assets
267
353
2,428
344
404
72
Total Current Assets
9,921
11,534
9,783
10,769
11,858
12,897
Net Property, Plant & Equipment
624
881
803
795
896
957
Total Investments and Advances
15
18
16
40
45
508
Long-Term Note Receivable
344
353
348
267
216
-
Intangible Assets
6,845
8,174
8,210
8,704
9,175
9,301
Total Assets
17,969
21,313
19,575
21,075
22,634
24,064
ST Debt & Current Portion LT Debt
125
1,075
1,885
-
975
Accounts Payable
1,295
1,262
1,122
1,000
1,132
Income Tax Payable
219
119
93
-
107
Other Current Liabilities
4,809
6,113
5,962
6,952
6,985
Total Current Liabilities
6,448
8,569
9,062
7,952
9,199
Long-Term Debt
4,361
4,958
3,065
5,272
4,369
Provision for Risks & Charges
131
259
140
142
158
Deferred Taxes
544
508
409
403
426
Other Liabilities
8
20
72
32
63
Total Liabilities
11,712
14,667
13,163
14,301
14,659
Common Equity (Total)
6,249
6,638
6,402
6,774
7,975
Total Shareholders' Equity
6,249
6,638
6,402
6,774
7,975
Total Equity
6,257
6,646
6,412
6,774
7,975
Liabilities & Shareholders' Equity
17,969
21,313
19,575
21,075
22,634
Accumulated Minority Interest
8
8
10
-
-

About Elekta AB

View Profile
Address
Kungstensgatan 18
Stockholm SD 103 93
Sweden
Employees -
Website http://www.elekta.com
Updated 07/08/2019
Elekta AB engages in the provision of clinical solutions for the treatment of cancers and brain disorders. Its products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: North and South America; Europe.